nDatalyze Past Earnings Performance
Past criteria checks 0/6
nDatalyze's earnings have been declining at an average annual rate of -22.4%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been declining at an average rate of 31.3% per year.
Key information
-22.4%
Earnings growth rate
-17.0%
EPS growth rate
| Healthcare Services Industry Growth | -3.9% |
| Revenue growth rate | -31.3% |
| Return on equity | -97.1% |
| Net Margin | -1,414.3% |
| Last Earnings Update | 31 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How nDatalyze makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Aug 24 | 0 | -1 | 1 | 0 |
| 31 May 24 | 0 | 0 | 0 | 0 |
| 29 Feb 24 | 0 | 0 | 0 | 0 |
| 30 Nov 23 | 0 | -1 | 1 | 0 |
| 31 Aug 23 | 0 | -1 | 0 | 0 |
| 31 May 23 | 0 | -1 | 1 | 0 |
| 28 Feb 23 | 0 | -1 | 1 | 0 |
| 30 Nov 22 | 0 | -2 | 0 | 1 |
| 31 Aug 22 | 0 | -2 | 0 | 1 |
| 31 May 22 | 0 | -1 | 0 | 1 |
| 28 Feb 22 | 0 | -1 | 0 | 1 |
| 30 Nov 21 | 1 | -1 | 1 | 0 |
| 31 Aug 21 | 1 | -1 | 1 | 0 |
| 31 May 21 | 1 | -1 | 1 | 0 |
| 28 Feb 21 | 1 | -1 | 1 | 0 |
| 30 Nov 20 | 1 | 0 | 0 | 0 |
| 31 Aug 20 | 1 | 0 | 0 | 0 |
| 31 May 20 | 1 | 0 | 0 | 0 |
| 29 Feb 20 | 1 | 0 | 0 | 0 |
| 30 Nov 19 | 0 | 0 | 0 | 0 |
| 31 Aug 19 | 0 | 0 | 0 | 0 |
| 31 May 19 | 0 | 0 | 0 | 0 |
| 28 Feb 19 | 0 | 0 | 0 | 0 |
Quality Earnings: NDAT is currently unprofitable.
Growing Profit Margin: NDAT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NDAT is unprofitable, and losses have increased over the past 5 years at a rate of 22.4% per year.
Accelerating Growth: Unable to compare NDAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NDAT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).
Return on Equity
High ROE: NDAT has a negative Return on Equity (-97.1%), as it is currently unprofitable.